300 episodes
Straight From The Cutter's Mouth: A Retina Podcast Jayanth Sridhar
-
- Education
-
-
4.5 • 4 Ratings
-
An informal yet insightful commentary featuring interviews and perspectives from leaders in vitreoretinal surgery as well as the next generation of retinal specialists
-
Episode 428: May 2024 Retinal Physician Preview Including Discussion of Retinal Prosthesis, Low Vision Aids, Home Monitoring, Digital OR
Drs. Kat Talcott and Sarwar Zahid join to preview the May 2024 edition of Retinal Physician, found online at http://www.retinalphysician.com.
Relevant Financial Disclosures: Dr. Zahid has equity in Eyedaptic.
You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi -
Episode 427: VBS 2024 Annual Meeting Recap with Drs. Finn, Williams, and Yonekawa
Drs. Avni Finn, Basil Williams, and Yoshihiro Yonekawa join to discuss their biggest learning pearls from the 2024 Vit-Buckle Society Annual Meeting.
Relevant Financial Disclosures: None
You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi -
Episode 426: Journal Club Discussion Including Inflammation Events with Faricimab, DRCR Protocol AC Post Hoc Analysis, Outcomes of Surgery for PDR, AI Interpretation of Images
-
Episode 425: April 2024 Retinal Physician Preview Including Discussion of Pipeline Targets and Durability Based Agents for Wet Age Related Macular Degeneration and Diabetic Retinopathy
Dr. Marianeli Rodriguez joins to preview the April 2024 edition of Retinal Physician, found online at http://www.retinalphysician.com.
Relevant Financial Disclosures: Dr. Sridhar has consulted for Genentech and Regeneron.
You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi -
Episode 424: Journal Club Discussion of Diabetic Retinopathy and Quality of Life Measures, Artificial Intelligence and Robotics in Ophthalmology, and Proliferative Sickle Cell Retinopathy Outcomes
Drs. Avni Finn and Sarwar Zahid join to discuss three recent publications from major ophthalmology journals.
Diabetic Retinopathy and Quality of Life (https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2814583)
Artificial Intelligence in Ophthalmology Review (https://www.ophthalmologyretina.org/article/S2468-6530(24)00044-7/abstract)
Proliferative Sickle Cell Retinopathy Surgical Outcomes (https://www.ophthalmologyretina.org/article/S2468-6530(24)00049-6/abstract)
Relevant Financial Disclosures: None
You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi -
Episode 423: Angiogenesis 2024 Recap with Dr. Philip Rosenfeld Including Discussion of Imaging for AMD, Geographic Atrophy Treatment Benefits and Risks, and More
Dr. Philip Rosenfeld joins to discuss the Angiogenesis 2024 meeting, with topics covered including imaging breakthroughs for age-related macular degeneration, geographic atrophy treatment benefits and risks, and the importance of molarity in assessing efficacy and safety of intravitreal agents.
Relevant Financial Disclosures: Dr. Rosenfeld has consulted for Regeneron and Zeiss. Dr. Sridhar has consulted for Apellis, Genentech, Iveric, and Regeneron.
You can claim CME credits for prior episodes via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audi
Customer Reviews
Brilliant stuff....
Extremely well researched topics with a great balance of journal clubs, surgical pearls, interviews with Stalwarts and tips on tricks on all aspects of Retina.
The general 6 or 8 minute talk and 2 minute discussion format of meetings misses out on so many nuances and subtle issues.
If "God is in the detail" - then this podcast is definitely heaven!
The elaborate discussion and detailed research of vital topics by Jay Sridhar really helps bring out all the "meat" on a variety of subjects.
The list of invitees is legendary it's a opportunity for anyone across the globe to learn from the masters.
One suggestion is that it the podcast is fairly US centric.. No doubt that's the way it's intended to be. A little mix of participants from across the globe would definitely make it even more appealing than it already is.
After 300 episodes it just keeps getting better and better!
Hats off...Keep it up!